Cancer Imaging and Technology Program Summary

[Program Summary| Members Search ]

The Mission of the Cancer Center Imaging and Technology Program (CITP) is to improve the capabilities and applications of imaging in the diagnosis and treatment of cancer. The main focus areas of the Cancer Center Imaging and Technology Program are as follows: 

• The use of imaging in cancer diagnosis and monitoring of therapy;

• The development of imaging applications at a molecular level using new imaging hardware and software.

Primary tenets of our program are that imaging is essentially a spectroscopic technique and that there is a continuum between images acquired on different platforms.  Hence, although there is a focus on in vivo imaging leading to clinical applications, our program encompasses images acquired from the sub-cellular to the organismal level and includes images from in vivo and ex vivo preparations.

 

In order to improve capabilities, we have members who can design, construct and optimize prototype instruments and contrast agents with improved windows of detection. This program is home to the most sophisticated and highest resolution SPECT instruments in the world and is the birthplace for unique optical detectors for in vivo imaging.  Unique contrast agents have been developed for optical imaging (two-photon dyes), magnetic resonance imaging (pH indicators) and ultrasound (microbubbles).  In order to improve applications, the program is actively developing new approaches to cancer diagnosis and monitoring of therapy.  These are occurring on four image acquisition platforms (magnetic resonance, optical, ultrasound and nuclear imaging).  Finally, an important future approach of in vivo imaging science is to image processes in defined ways by taking advantage of the wealth of biomolecular informatics. 

 

 

For more information, please contact: 

Arthur Gmitro, PhD

Program Leader

(520) 626-5050

 

Webmaster | Privacy Policy | Disclaimer
Arizona Cancer Center :: 1515 North Campbell Ave., Tucson, AZ 85724-5024
Copyright ABOR :: All rights reserved.